Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques

Afam A. Okoye, Maren Q. DeGottardi, Yoshinori Fukazawa, Mukta Vaidya, Chike O. Abana, Audrie L. Konfe, Devin N. Fachko, Derick M. Duell, He Li, Richard Lum, Lina Gao, Byung S. Park, Rebecca L. Skalsky, Anne D. Lewis, Michael K. Axthelm, Jeffrey D. Lifson, Scott W. Wong and Louis J. Picker
J Immunol October 25, 2019, ji1900792; DOI: https://doi.org/10.4049/jimmunol.1900792
Afam A. Okoye
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maren Q. DeGottardi
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshinori Fukazawa
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mukta Vaidya
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chike O. Abana
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrie L. Konfe
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devin N. Fachko
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Devin N. Fachko
Derick M. Duell
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
He Li
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Lum
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina Gao
‡Division of Biostatistics, Department of Public Health and Preventative Medicine, Oregon Health & Science University, Portland, OR 97239; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung S. Park
‡Division of Biostatistics, Department of Public Health and Preventative Medicine, Oregon Health & Science University, Portland, OR 97239; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Byung S. Park
Rebecca L. Skalsky
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne D. Lewis
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne D. Lewis
Michael K. Axthelm
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael K. Axthelm
Jeffrey D. Lifson
§AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott W. Wong
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis J. Picker
*Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006;
†Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Key Points

  • Anti–IL-15 depletes NK cells and disrupts TEM homeostasis in SIV-infected RM.

  • IL-15 inhibition does not alter SIV replication dynamics or CD4+ T cell depletion.

  • IL-15 inhibition does accelerate reactivation of an oncogenic γ-herpesvirus.

Abstract

Although IL-15 has been implicated in the pathogenic hyperimmune activation that drives progressive HIV and SIV infection, as well as in the generation of HIV/SIV target cells, it also supports NK and T cell homeostasis and effector activity, potentially benefiting the host. To understand the role of IL-15 in SIV infection and pathogenesis, we treated two cohorts of SIVmac239-infected rhesus macaques (RM; Macaca mulatta), one with chronic infection, the other with primary infection, with a rhesusized, IL-15–neutralizing mAb (versus an IgG isotype control) for up to 10 wk (n = 7–9 RM per group). In both cohorts, anti–IL-15 was highly efficient at blocking IL-15 signaling in vivo, causing 1) profound depletion of NK cells in blood and tissues throughout the treatment period; 2) substantial, albeit transient, depletion of CD8+ effector memory T cells (TEM) (but not the naive and central memory subsets); and 3) CD4+ and CD8+ TEM hyperproliferation. In primary infection, reduced frequencies of SIV-specific effector T cells in an extralymphoid tissue site were also observed. Despite these effects, the kinetics and extent of SIV replication, CD4+ T cell depletion, and the onset of AIDS were comparable between anti–IL-15– and control-treated groups in both cohorts. However, RM treated with anti–IL-15 during primary infection manifested accelerated reactivation of RM rhadinovirus. Thus, IL-15 support of NK cell and TEM homeostasis does not play a demonstrable, nonredundant role in SIV replication or CD4+ T cell deletion dynamics but may contribute to immune control of oncogenic γ-herpesviruses.

Footnotes

  • This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease (Grants R37AI054292 and UM1AI126611-02 [to L.J.P.] and P51OD011092 [to M. K. A. and A.D.L.]) and supported in part with federal funds from the National Cancer Institute (contract HHSN261200800001E [to J.D.L.] and R01CA206404 [to S.W.W.]). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

  • The online version of this article contains supplemental material.

  • Received July 11, 2019.
  • Accepted September 30, 2019.
  • Copyright © 2019 by The American Association of Immunologists, Inc.
PreviousNext
Back to top

In this issue

The Journal of Immunology: 209 (4)
The Journal of Immunology
Vol. 209, Issue 4
15 Aug 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques
Afam A. Okoye, Maren Q. DeGottardi, Yoshinori Fukazawa, Mukta Vaidya, Chike O. Abana, Audrie L. Konfe, Devin N. Fachko, Derick M. Duell, He Li, Richard Lum, Lina Gao, Byung S. Park, Rebecca L. Skalsky, Anne D. Lewis, Michael K. Axthelm, Jeffrey D. Lifson, Scott W. Wong, Louis J. Picker
The Journal of Immunology October 25, 2019, ji1900792; DOI: 10.4049/jimmunol.1900792

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques
Afam A. Okoye, Maren Q. DeGottardi, Yoshinori Fukazawa, Mukta Vaidya, Chike O. Abana, Audrie L. Konfe, Devin N. Fachko, Derick M. Duell, He Li, Richard Lum, Lina Gao, Byung S. Park, Rebecca L. Skalsky, Anne D. Lewis, Michael K. Axthelm, Jeffrey D. Lifson, Scott W. Wong, Louis J. Picker
The Journal of Immunology October 25, 2019, ji1900792; DOI: 10.4049/jimmunol.1900792
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection
  • Duck CD8+ T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro
  • Arid5a Mediates an IL-17–Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense
Show more INFECTIOUS DISEASE AND HOST RESPONSE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606